<!DOCTYPE HTML>
<html lang="en">
<head>
<!-- Generated by javadoc (20) -->
<title>Source code</title>
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta name="description" content="source: package: org.biopax.paxtools.model.level3, interface: CovalentBindingFeature">
<meta name="generator" content="javadoc/SourceToHTMLConverter">
<link rel="stylesheet" type="text/css" href="../../../../../../stylesheet.css" title="Style">
</head>
<body class="source-page">
<main role="main">
<div class="source-container">
<pre><span class="source-line-no">001</span><span id="line-1">package org.biopax.paxtools.model.level3;</span>
<span class="source-line-no">002</span><span id="line-2"></span>
<span class="source-line-no">003</span><span id="line-3">/**</span>
<span class="source-line-no">004</span><span id="line-4"> * &lt;b&gt;Definition:&lt;/b&gt; An entity feature that represent the covalently bound state of  a physical entity.</span>
<span class="source-line-no">005</span><span id="line-5"> *</span>
<span class="source-line-no">006</span><span id="line-6"> * Rationale: Most frequent covalent modifications to proteins and DNA, such as phosphorylation and</span>
<span class="source-line-no">007</span><span id="line-7"> * metylation are covered by the ModificationFeature class. In these cases, the added groups are</span>
<span class="source-line-no">008</span><span id="line-8"> * simple and stateless therefore they can be captured by a controlled vocabulary. In other cases,</span>
<span class="source-line-no">009</span><span id="line-9"> * such as ThiS-Thilacyl-disulfide, the covalently linked molecules are best represented as a</span>
<span class="source-line-no">010</span><span id="line-10"> * molecular complex. CovalentBindingFeature should be used to model such covalently linked</span>
<span class="source-line-no">011</span><span id="line-11"> * complexes.</span>
<span class="source-line-no">012</span><span id="line-12"> *</span>
<span class="source-line-no">013</span><span id="line-13"> * Usage: Using this construct, it is possible to represent small molecules as a covalent complex of</span>
<span class="source-line-no">014</span><span id="line-14"> * two other small molecules. The demarcation of small molecules is a general problem and is</span>
<span class="source-line-no">015</span><span id="line-15"> * delegated to small molecule databases.The best practice is not to model using covalent complexes</span>
<span class="source-line-no">016</span><span id="line-16"> * unless at least one of the participants is a protein, DNA or RNA.</span>
<span class="source-line-no">017</span><span id="line-17"> *</span>
<span class="source-line-no">018</span><span id="line-18"> * Examples: disulfide bond UhpC + glc-6P -&amp;gt; Uhpc-glc-6p acetyl-ACP -&amp;gt; decenoyl-ACP charged tRNA</span>
<span class="source-line-no">019</span><span id="line-19"> */</span>
<span class="source-line-no">020</span><span id="line-20">public interface CovalentBindingFeature extends BindingFeature, ModificationFeature</span>
<span class="source-line-no">021</span><span id="line-21">{</span>
<span class="source-line-no">022</span><span id="line-22"></span>
<span class="source-line-no">023</span><span id="line-23">}</span>




























































</pre>
</div>
</main>
</body>
</html>
